Find Research Outputs

Search concepts
Selected Filters
2019

2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in systemic lupus erythematosus and cancer

Malaer, J. D., Marrufo, A. M. & Mathew, P., 1 Jul 2019, In : Clinical Immunology. 204, p. 50-56 7 p.

Research output: Contribution to journalReview article

Natural Killer Cells
Systemic Lupus Erythematosus
Multiple Myeloma
Natural Killer Cell Receptors
T-Lymphocytes
2018
1 Citation (Scopus)

A novel ligand on astrocytes interacts with natural cytotoxicity receptor NKp44 regulating immune response mediated by NK cells

Bowen, K. E., Mathew, S. O., Borgmann, K., Ghorpade, A. & Mathew, P. A., Feb 2018, In : PLoS ONE. 13, 2, e0193008.

Research output: Contribution to journalArticle

Natural Cytotoxicity Triggering Receptor 2
astrocytes
natural killer cells
Cytotoxicity
Astrocytes
2017
12 Citations (Scopus)

CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma

Malaer, J. D. & Mathew, P., 1 Jan 2017, In : American Journal of Cancer Research. 7, 8, p. 1637-1641 5 p.

Research output: Contribution to journalReview article

Multiple Myeloma
Natural Killer Cells
Immunotherapy
Natural Killer Cell Receptors
Antibody-Dependent Cell Cytotoxicity
2016
7 Citations (Scopus)

Blimp-1/PRDM1 regulates the transcription of human CS1 (SLAMF7) gene in NK and B cells

Kim, J. R., Mathew, S. O. & Mathew, P., 1 Jan 2016, In : Immunobiology. 221, 1, p. 31-39 9 p.

Research output: Contribution to journalArticle

Natural Killer Cells
B-Lymphocytes
Multiple Myeloma
Genetic Promoter Regions
Genes
10 Citations (Scopus)
Natural Killer Cells
Prostatic Neoplasms
Natural Killer Cell Receptors
Cell Line
Second Primary Neoplasms
2015
24 Citations (Scopus)

NKp44 and natural cytotoxicity receptors as damage-associated molecular pattern recognition receptors

Horton, N. C. & Mathew, P. A., 1 Jan 2015, In : Frontiers in Immunology. 6, FEB, 00031.

Research output: Contribution to journalArticle

Pattern Recognition Receptors
Natural Killer Cells
Ligands
Natural Cytotoxicity Triggering Receptor 3
Neoplasms